ChronTech’s IVIN technology allows for lower vaccine doses with maintained efficacy
New studies have now shown that ChronTech’s IVIN technology is so efficacious that a far better immune response is achievable using the same or even much lower doses of DNA than when using a regular injection needle, irrespective of whether the injection is used in combination with in vivo electroporation or not. IVIN increases the number of vaccine specific T cells by more than 100% as compared to a regular needle when in combination with electroporation. Using IVIN strong immune responses can be achieved even when the dose is reduced 100-folds. The opportunity to reduce the amount of